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Abstract. Medical significance of heart failure (HF) is obvious; it results from high prevalence, morbidity and 
mortality rate. Acute cardiogenic pulmonary edema (ACPE) is an emergency, the most severe retrograde left 
ventricular (LV) insufficiency. PubMed search revealed not a single paper with the objective to evaluate atrial 
fibrillation (AF) prevalence and prognostic significance in ACPE patients. Given the lack of information on the 
clinically very relevant topic, the aim of the study was to analyze prevalence, pathophysiologic consequences and 
possible prognostic significance of AF in ACPE. We studied homogenous group of 1397 ACPE patients, including 
those in cardiogenic shock, but without concomitant acute myocardial infarction (AMI). Prevalence of AF in ACPE 
was 29.74%. Intra-hospital mortality of ACPE patients with AF was 20.05% vs. 12.85% in patients without AF 
(p=0.00078). In conclusion, prevalence of AF is very high in the largest published homogenous acute cardiogenic 
pulmonary edema series (without AMI). Pathophysiologic mechanisms of AF-induced clinical course detrimental 
effects include impairment of left ventricle function (even critically), as well as induction / worsening of ischemia, etc. 
AF is associated with (almost) doubled mortality in acute cardiogenic pulmonary edema. AF was a better predictor of 
in-hospital mortality then LV ejection fraction, diabetes mellitus, and many others. 
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Introduction

 
Medical significance of heart failure (HF) is indisputable, 
resulting from high prevalence, morbidity and mortality. 
Prevalence of HF is believed to be 1–2% in developed 
countries [1]. One in five adults will have HF during 
lifetime, and average 1-year mortality rate is very high 
(23.4%) [2]. The estimation suggested 3-fold increase in 
HF hospitalizations from 1996 to 2050 [2]. Before 1990, 
the modern era of treatment, 60–70% of HF patients did 
not manage to survive first five years [1]. 
Acute cardiogenic pulmonary edema (ACPE) is an 
emergency, the most severe retrograde left ventricular 
(LV) insufficiency, associated with substantial mortality 
rate, both short- and long-term [3, 4]. Patients with 
ACPE show some differences in comparison with other 
acute HF patients, for example, higher hemoglobin level 
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on admission and a more pronounced decrease during 
the first day of hospitalization [5].  
Atrial fibrillation (AF) is the most common chronic 
arrhythmia, and it is associated with a 2-fold increased 
risk of mortality [6]. AF is also the most common 
arrhythmia in HF; the prevalence of AF in acute HF is 
>30%. AF does increase the thrombo-embolic risk 
(especially stroke) and it worsens HF symptoms [2]. AF 
can cause systolic HF (“tachycardiomyopathy”) [2]. 
PubMed search conducted on 6/13/2015 for the 
terms “pulmonary edema atrial fibrillation patients” 
revealed 194 papers, none with the objective to evaluate 
AF prevalence and prognostic significance in pulmonary 
edema patients.  
Given the lack of information on the clinically very 
relevant topic, the aim of the study was to analyze 
prevalence, pathophysiologic consequences and possible 
prognostic significance of AF in ACPE. 
Material and Methods 
We studied homogenous group of 1397 ACPE patients, 
including those in cardiogenic shock, but without 
concomitant acute myocardial infarction (AMI) [7]. 
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Patients had crackles in >50% of lung field, as well as 
oxygen saturation <95% and were hospitalized at the 
Department for Cardiovascular Diseases, Clinical 
Center of Niš, during the period 1993–2005 [7].  
The average age was 69.989.48 years (23-94 years) 
and males were slightly predominant (50.9%). Coronary 
artery disease and arterial hypertension were the most 
important etiologic factors. Protocol consisted of 25 
parameters. Statistical analysis was done by commercial 
program SPSS, Chicago, Illinois, version 19. P-values 
of <0.05 were considered significant. 
Results 
Prevalence of AF in ACPE was 29.74%. The average age 
was 72.3±9.1 years in patients with AF and 69.1±9.5 
years in those without AF (p<0.000001). In-hospital 
mortality of ACPE patients with AF was 20.05% vs 
12.85% in patients without AF (p=0.00078) (Fig. 1).   
 
Fig. 1. In-hospital mortality of ACPE patients with vs 
without AF. ACPE, acute cardiogenic pulmonary 
edema; AF, atrial fibrillation 
Pulse pressure (difference between systolic and 
diastolic blood pressure) was statistically significantly 
lower in ACPE patients with vs without AF (43.7±37.8 
mmHg vs 49.0±37.3 mmHg; p=0.0334) (Fig. 2).   
 
Fig. 2. Pulse pressure in ACPE patients with vs without 
AF. ACPE, acute cardiogenic pulmonary edema; 
AF, atrial fibrillation 
The average heart rate on admission in ACPE patients 
with AF was 123.9±33.2 beats per minute (bpm), 
significantly higher as compared to patients without AF 
(107.6±26.2 bpm; p<0.000001) (Fig. 3). 
Interventricular septum diastolic dimension was 
higher in patients with AF (12.8±2.2 mm) vs patients 
without AF (12.0±2.6 mm; p<0.05). No significant 
differences were found in: gender prevalence, prevalence 
of diabetes mellitus and of chronic obstructive lung 
disease, LV diastolic diameter, LV ejection fraction, 
prevalence of LV with preserved systolic function, systolic 
blood pressure (BP), diastolic BP, serum glucose level, 
white blood cell count, blood urea nitrogen and creatinine, 
as well as K
+
 and Na
+
 serum concentration. 
Discussion  
The prevalence of AF in ACPE was very high (29.74%), 
just as might be expected according to the medical 
literature. Acute and Chronic Heart Failure Guidelines of 
the European Society of Cardiology, published in 2012, 
cite the prevalence of AF in acute HF > 30% [1].  
The average age was significantly higher (3.2 years; 
p<0.000001) in patients with AF compared to patients 
without AF. This was not surprising, as AF is 
predominantly the disease of aged population (AF is up 
to 90 times more prevalent in persons >80 years) [8]. 
AF was associated with almost doubled in-hospital 
mortality of our ACPE patients (20.05% vs 12.85%; 
p=0.00078; see Fig. 1). This is, to our knowledge, 
documented for the first time in such large homogenous 
series of ACPE patients without AMI.   
As early as 1938, as cited by Gallagher and Camm 
[9], Brill observed that AF may cause HF without any 
other heart disease and following AF cease, recovery 
may be complete and long lasting. AF is a strong 
independent risk factor for HF [1]. Namely, AF is 
associated with a  increased risk of HF [6]. Vice 3-fold
versa, HF increases the chances for AF even 4.5 times 
(in men) to 5.9 times (in women) [10]. The higher the 
New York Heart Association (NYHA) class, the higher 
the AF prevalence in HF patients (from 4% in NYHA 
class I, to 40% in NYHA class IV) [1].  
In our study, the average heart rate on admission in 
ACPE patients with AF was significantly higher than in 
patients without AF (16.3 bpm; p<0.000001) (see Fig. 
3). It is an important and expected finding, because 
there is a clear association between uncontrolled heart 
rate and development of HF [1]. Moreover, there is a 
clear need to control high HR in acute HF, including 
ACPE. AF can worsen HF symptoms and worsened HF 
 
Fig. 3. Heart rate at admission in ACPE patients with vs 
without AF. ACPE, acute cardiogenic pulmonary 
edema; AF, atrial fibrillation 
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can substantially increase heart rate in AF [1]. Patients 
with HF and preserved left ventricular ejection fraction 
(LVEF) are older and more often female and obese, less 
likely to have coronary artery disease and more likely to 
have AHT and AF than those with HF and reduced LVEF 
[1]. Underlying co-morbidities or subtle alterations (such 
as mild left atrial dilatation or low-normal LVEF), in the 
absence of overt heart disease, are baseline independent 
risk factors for incident HF during a long-term follow-up. 
Furthermore, incident HF is an independent predictor of 
adverse outcomes [11]. 
Conclusion  
1. Prevalence of AF is very high (29.74%) in the 
largest published homogenous acute cardiogenic 
pulmonary edema series (without AMI).  
2. Pathophysiologic mechanisms of AF-induced clinical 
course harmful effects include impairment of left 
ventricle function (even critically), as well as induction/ 
worsening of ischemia.  
3. AF is associated with (almost) doubled mortality in 
acute cardiogenic pulmonary edema.  
4. AF was the better predictor of in-hospital mortality 
then LVEF, diabetes mellitus, and many others.  
5. Heart rate control/cardioversion are very important 
goals in therapy of acute cardiogenic pulmonary 
edema, with amiodarone and direct current 
cardioversion as first line therapy. 
Acknowledgment. This work has been supported by the Ministry 
of Education and Science, Serbia; grant no. III41018. 
References
1. McMurray JJ, Adamopoulos S, Anker SD, et al.  ESC guidelines 
for the diagnosis and treatment of acute and chronic heart failure 
2012: The task force for the diagnosis and treatment of acute and 
chronic heart failure 2012 of the European Society of Cardiology. 
Developed in collaboration with the Heart Failure Association 
(HFA) of the ESC. Eur J Heart Fail 2012; 14:803–869.  
2. O'Meara E, Thibodeau-Jarry N, Ducharme A, Rouleau JL. The 
epidemic of heart failure: a lucid approach to stemming the rising 
tide. Can J Cardiol 2014; 30:S442–454. 
3. Schmickl CN, Biehl M, Wilson GA, Gajic O. Comparison of 
hospital mortality and long-term survival in patients with acute lung 
injury/ARDS vs cardiogenic pulmonary edema. Chest 2015; 147: 
618–625. 
4. Marcinkiewicz M, Ponikwicka K, Szpakowicz A, Musiał WJ, 
Kamiński KA. Cardiogenic pulmonary oedema: alarmingly poor 
long term prognosis. Analysis of risk factors. Kardiol Pol 2013; 
71:712–720. 
5. Konishi M, Matsuzawa Y, Suzuki H, et al. Higher level at 
admission and subsequent decline in hemoglobin in patients 
with acute pulmonary edema. Circ J 2014; 78:896–902. 
6. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS 
guideline for the management of patients with atrial fibrillation. A 
report of the American College of Cardiology/American Heart 
Association task force on practice guidelines and the Heart Rhythm 
Society. J Am Coll Cardiol 2014; 64:e1–76.  
7. Koracevic G, Cvetkovic E, Tomasevic M, et al. Atrial fibrillation 
doubled in-hospital mortality in 1397 acute cardiogenic pulmonary 
edema patients. Circulation 2010; 122:669. 
8. Abusada K, Sharma SB, Jaladi R, Ezekowity MD. Epidemiology 
and management of new-onset atrial fibrillation. Am J Manag Care 
2004; 10:s50–57. 
9. Gallagher M, Camm J. Classification of atrial fibrillation. Am J 
Cardiol 1998; 82:18N–28N. 
10. Kannel W, Wolf P, Benjamin E, Levy D. Prevalence, incidence, 
prognosis and predisposing conditions for atrial fibrillation: 
population-based estimates. Am J Cardiol 1998; 82:2N–9N.  
11. Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Lip GY. 
Predictors and prognostic implications of incident heart failure 
following the first diagnosis of atrial fibrillation in patients with 
structurally normal heart: the Belgrade atrial fibrilation study. Eur J 
Heart Fail 2013; 15:415–424. 
 
